Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem Yamout

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
CNS Drugs|September 6, 2024
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry StudyDaniel Kreiter, Tomas Kalincik, Raymond Hupperts, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2024
Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohortGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
Neurodegenerative Disease Management|August 3, 2023
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS studyGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2023
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective studyGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
The International Journal of Neuroscience|August 10, 2013
Multiple sclerosis in the Levant: a regional consensus statementBassem Yamout, Khalid El-Salem, Souheil Gebeily, et al.
Journal of Neuroimmunology|August 24, 2010
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot studyBassem Yamout, Roula Hourani, Haytham Salti, et al.
Therapeutic Advances in Neurological Disorders|April 30, 2025
Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab EmiratesJihad Inshasi, Yomna Nowier, Evelina A Zimovetz, et al.
Multiple Sclerosis and Related Disorders|December 24, 2022
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidenceCelia Oreja-Guevara, Wallace Brownlee, Elisabeth G Celius, et al.
CNS Drugs|June 24, 2021
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018Nahid Moradi, Sifat Sharmin, Charles Malpas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2022
External validation of a clinical prediction model in multiple sclerosisNahid Moradi, Sifat Sharmin, Charles B Malpas, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
CNS Drugs|September 6, 2024
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry StudyDaniel Kreiter, Tomas Kalincik, Raymond Hupperts, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2024
Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohortGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
Neurodegenerative Disease Management|August 3, 2023
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS studyGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2023
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective studyGavin Giovannoni, Alexey Boyko, Jorge Correale, et al.
The International Journal of Neuroscience|August 10, 2013
Multiple sclerosis in the Levant: a regional consensus statementBassem Yamout, Khalid El-Salem, Souheil Gebeily, et al.
Journal of Neuroimmunology|August 24, 2010
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot studyBassem Yamout, Roula Hourani, Haytham Salti, et al.
Therapeutic Advances in Neurological Disorders|April 30, 2025
Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab EmiratesJihad Inshasi, Yomna Nowier, Evelina A Zimovetz, et al.
Multiple Sclerosis and Related Disorders|December 24, 2022
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidenceCelia Oreja-Guevara, Wallace Brownlee, Elisabeth G Celius, et al.
CNS Drugs|June 24, 2021
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018Nahid Moradi, Sifat Sharmin, Charles Malpas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2022
External validation of a clinical prediction model in multiple sclerosisNahid Moradi, Sifat Sharmin, Charles B Malpas, et al.
Pageof 9